Stay updated on Eteplirsen in DMD Exon 51 Skipping Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen in DMD Exon 51 Skipping Clinical Trial page.

Latest updates to the Eteplirsen in DMD Exon 51 Skipping Clinical Trial page
- Check5 days agoChange DetectedUpdated the page from v3.0.1 to v3.0.2 and removed the 'Back to Top' link. No substantive content changes occurred.SummaryDifference0.2%
- Check12 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check19 days agoChange DetectedThe web page has been updated to include specific details about the facility and its location in Ghent, Belgium, as well as new publications related to Duchenne muscular dystrophy and the drug eteplirsen. Notably, the previous version's references to Gent, Belgium, and various muscular dystrophy topics have been removed.SummaryDifference7%
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Eteplirsen in DMD Exon 51 Skipping Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen in DMD Exon 51 Skipping Clinical Trial page.